Category Archives: Cardiology

Insurance companies are not paying for Repatha and Praluent

March 8, 2017- Interviewed by Steven E. Greer, MD We interviewed cardiologist William O’Neill, MD about his personal need for the cholesterol-lowering, large-molecule, antibody drug from Amgen, branded as Repatha. Despite

Posted in - Biotech, - Pharma, - Policy, Cardiac surgery, Cardiology, Henry Ford, Primary care medicine | 1 Comment

Are the new PCSK9 cholesterol lowering drugs worth the high cost?

December 16, 2015- Interviewed by Steven E. Greer, MD

Posted in - Biotech, - NEJM, - Opinion, - Pharma, - Policy, Cardiology, CMS, FDA | Leave a comment

An emerging safety problem for TAVR patients

March 16, 2017- produced and interviewed by Steven E. Greer, MD We interviewed William O’Neill, MD, one of the first to implant a Transcatheter Aortic Valve Replacement (TAVR) valve. The products have been approved by the FDA for several years, … Continue reading

Posted in - Medical Devices, Cardiac surgery, Cardiology, FDA | Leave a comment

The Lotus TAVR valve recall

March 16, 2017- produced and interviewed by Steven E. Greer, MD We interviewed William O’Neill, MD, one of the first to implant a Transcatheter Aortic Valve Replacement

Posted in - Medical Devices, Cardiac surgery, Cardiology, FDA | Leave a comment

Interview with the CEO of Neovasc, Alexei Marko

Posted in - Medical Devices, Cardiology, FDA | Leave a comment

CBS promotes outrageous pro-coffee research, again

Update May 8, 2016- HBO’s John Oliver focused on this problem of TV news misrepresenting the

Posted in - Opinion, - Policy, Cardiology, Primary care medicine, Psychology Psychiatry, Urology | Leave a comment

Did Hillary Clinton really faint from “dehydration” or does she have a chronic neurological condition?

September 12, 2016- by Steven E. Greer, MD Once again, the Hillary Clinton campaign is on defense after another health scare from their

Posted in - Policy, Cardiology, Congress, Emergency medicine, Neurology, NYU, Ophthalmology, Primary care medicine, Radiology | Leave a comment

10-year follow-up on the CREST carotid stenting trial

March 4, 2016- Interviewed by Steven E. Greer, MD The 10-year follow-up data on the CREST carotid stenting vs. CEA trail were published

Posted in - Medical Devices, - NEJM, Cardiac surgery, Cardiology, Neurology, Neurosurgery, Vascular Surgery | Leave a comment

Man who oversaw one of the biggest academic research frauds in medical history is poised to become the next FDA Commissioner

Update February 7, 2016- Key senators, including Bernie Sanders, are now threatening to filibuster

Posted in - Opinion, - Policy, Cardiology, FDA, NIH | Leave a comment

Review of the TCT 2015 data

October 19, 2015

Posted in - Medical Devices, Cardiac surgery, Cardiology, Henry Ford | Leave a comment

Review of the TAVR data from the 2015 ACC

May 7, 2015- Interviewed by Steven E. Greer, MD

Posted in - Medical Devices, Cardiac surgery, Cardiology, UCLA | Leave a comment

The Sapien 3 TAVR valve

September 9, 2015- By Steven E. Greer, MD We interviewed William O’Neill, MD, a principal investigator for the Edwards Lifesciences Sapien valve trials,

Posted in Cardiology | Leave a comment

Can a “calculator” really tell doctors who should be on Lipitor?

November 13, 2013- By Steven E. Greer, MD The AHA released the long-awaited new guidelines that recommend which patients should be

Posted in Cardiology, Uncategorized | Leave a comment

The newly approved Edwards Lifesciences Sapien 3 aortic valve

July 5, 2015- Interviewed by Steven E. Greer, MD We interviewed William Suh, MD of UCLA about the newly approved Edwards Lifesciences Sapien

Posted in - Medical Devices, Cardiac surgery, Cardiology, FDA, UCLA | Leave a comment

Astronaut and Senator John Glenn suffers stroke after TAVR

May 14, 2015- By Steven E. Greer, MD Stroke is the bane of TAVR. In the Edwards Lifesciences Sapien valve, stroke rates exceed 10%.

Posted in - Medical Devices, - Opinion, Cardiology | Leave a comment

Brigham and Women’s Hospital engages in bizarre PR campaign for daily aspirin

 April 21, 2015- By Steven E. Greer, MD Brigham and Women’s Hospital in Boston, part of the Harvard University network of hospitals,

Posted in - Policy, Cardiology, Harvard, Neurology, Oncology | Leave a comment

CT-scan screening for heart disease fails to show benefit

March 23, 2015- Interviewed by Steven E. Greer, MD We interviewed the Principal Investigator of the PROMISE trial, Pamela Douglas, MD from Duke.

Posted in - NEJM, - Policy, Cardiology, CMS, Duke, Radiology | Leave a comment

The PCSK9 LDL drugs do not cut heart risk in half

March 18, 2015- Op-Ed by Steven E. Greer, MD The American College of Cardiology (ACC) meeting is underway, and the main Late Breaking data

Posted in - Biotech, - Opinion, Cardiac surgery, Cardiology, Primary care medicine | Leave a comment

The deadly risks of TAVR being downplayed to patients by hospitals

January 18, 2015- By Steven E. Greer, MD On July 20th, 2011, the FDA convened an advisory committee to help it determine whether to

Posted in - Medical Devices, - Opinion, Cardiac surgery, Cardiology, FDA | Leave a comment

Daily aspirin once again proves to be of no use and also deadly

Update January 13, 2015- Yet another study was published highlighting the risks of daily aspirin. 

Posted in - JAMA, - Pharma, - Policy, Cardiac surgery, Cardiology, Gastroenterology and liver, General surgery, Neurology, Neurosurgery, Oncology, Primary care medicine | Leave a comment